-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[ Star Enterprise of Chemical Machinery and Equipment Network ] In recent years, China's economy has developed rapidly, the living standards of residents have been continuously improved, and the demand for medical care has also begun to continue to grow.
In this context, superimposed on the general trend of medical system reform, the domestic pharmaceutical market has also begun to usher in a period of rapid development.
However, it is worth noting that the pharmaceutical industry is closely related to pharmaceutical equipment .
At the same time as the pharmaceutical industry is ushering in a golden period of development, it will inevitably bring opportunities to the upstream pharmaceutical equipment industry and put forward higher requirements for related pharmaceutical equipment.
Chemical machinery equipment network star enterprise chemical machinery equipment pharmaceutical equipmentIn this context, superimposed on the general trend of medical system reform, the domestic pharmaceutical market has also begun to usher in a period of rapid development.
However, it is worth noting that the pharmaceutical industry is closely related to pharmaceutical equipment .
At the same time as the pharmaceutical industry is ushering in a golden period of development, it will inevitably bring opportunities to the upstream pharmaceutical equipment industry and put forward higher requirements for related pharmaceutical equipment.
It is understood that in the past, due to the low concentration of my country's pharmaceutical equipment industry, most small and medium-sized enterprises lacked high value-added products with independent intellectual property rights, which led to fierce competition among domestic pharmaceutical equipment companies* in the middle and low-end markets.
And when compared with foreign-funded products in the market, it appears rough in appearance, low in automation, and lack of humanity.
And when compared with foreign-funded products in the market, it appears rough in appearance, low in automation, and lack of humanity.
In recent years, in the fierce competition, pharmaceutical companies have increasingly realized that only by solid development and building core technologies can they go more stable and farther.
Therefore, with the continuous development of automation, informatization, and intelligent technology, many pharmaceutical equipment companies have begun to vigorously explore the direction of intelligence in order to achieve overtaking in curves.
It is reported that a large number of large-scale pharmaceutical equipment companies with capital and technology have begun to show results in the context of deploying intelligence in the field.
Therefore, with the continuous development of automation, informatization, and intelligent technology, many pharmaceutical equipment companies have begun to vigorously explore the direction of intelligence in order to achieve overtaking in curves.
It is reported that a large number of large-scale pharmaceutical equipment companies with capital and technology have begun to show results in the context of deploying intelligence in the field.
For example, Chutian Technology approved its new smart manufacturing model project in Ningxiang, Changsha in July.
It is understood that the project realizes the full life cycle management of products from the entire process of R&D, manufacturing, logistics, service, etc.
, and creates a new mode of smart manufacturing and smart manufacturing standards for pharmaceutical equipment, which is conducive to promoting my country's pharmaceutical equipment companies to adopt a new mode of smart manufacturing.
change.
In addition, the completion of the project will not only continue to improve the overall operational efficiency of pharmaceutical equipment industry enterprises and the overall intelligent level of pharmaceutical equipment, but will also greatly improve the level of pharmaceutical equipment in my country.
It is understood that the project realizes the full life cycle management of products from the entire process of R&D, manufacturing, logistics, service, etc.
, and creates a new mode of smart manufacturing and smart manufacturing standards for pharmaceutical equipment, which is conducive to promoting my country's pharmaceutical equipment companies to adopt a new mode of smart manufacturing.
change.
In addition, the completion of the project will not only continue to improve the overall operational efficiency of pharmaceutical equipment industry enterprises and the overall intelligent level of pharmaceutical equipment, but will also greatly improve the level of pharmaceutical equipment in my country.
Of course, in addition to creating new model projects for biomedical robots and equipment intelligent manufacturing, Chutian Technology has also gradually built a technology and product line platform such as intelligent aseptic packaging technology product lines, intelligent system integration and special packaging technology product lines in recent years.
Intelligent pharmaceutical production overall technical solutions, these intelligent products not only promote the intelligent level of pharmaceutical production, but also provide a higher level of guarantee for the quality and safety of pharmaceutical production.
Intelligent pharmaceutical production overall technical solutions, these intelligent products not only promote the intelligent level of pharmaceutical production, but also provide a higher level of guarantee for the quality and safety of pharmaceutical production.
In addition to Chutian, Tofflon is also working hard to implement the vision of "smart factory deliverer".
In recent years, it has made breakthroughs in automation, informatization, continuity, and intelligence.
At the same time, it has also gained new markets on the road of chemical development.
At present, some of its intelligent products have successfully entered the high-regulation markets in Western Europe and North America, and some high-level production lines such as anti-tumor have also entered the European and American markets.
In recent years, it has made breakthroughs in automation, informatization, continuity, and intelligence.
At the same time, it has also gained new markets on the road of chemical development.
At present, some of its intelligent products have successfully entered the high-regulation markets in Western Europe and North America, and some high-level production lines such as anti-tumor have also entered the European and American markets.
In addition, some companies are aiming at the integrated development of intelligent equipment R&D, manufacturing and marketing in the field of health.
At present, the company’s market development is proceeding in an orderly manner in accordance with the annual plan, and has basically formed a sales network in key regions with the South China and East China markets as the main line, and the Central China, Southwest, North China and Northwest markets as auxiliary lines.
The initial coverage of the sales network, as well as soft capsules, The market development pattern of some regional enterprise application demonstration project cases of products such as preparations, targeted drugs and small molecule drugs.
At present, the company’s market development is proceeding in an orderly manner in accordance with the annual plan, and has basically formed a sales network in key regions with the South China and East China markets as the main line, and the Central China, Southwest, North China and Northwest markets as auxiliary lines.
The initial coverage of the sales network, as well as soft capsules, The market development pattern of some regional enterprise application demonstration project cases of products such as preparations, targeted drugs and small molecule drugs.
In fact, in the face of fierce competition in the pharmaceutical equipment industry and high product overlap, for pharmaceutical equipment companies, especially small and medium-sized pharmaceutical equipment companies, full automation and intelligence have become key factors to improve market competitiveness.
It can not only help pharmaceutical companies achieve continuous production and improve production efficiency, but also reduce manual error rates and reduce production and loss costs.
In this context, the industry also generally believes that full automation and intelligence will be an irreversible new development trend in the equipment industry.
It can not only help pharmaceutical companies achieve continuous production and improve production efficiency, but also reduce manual error rates and reduce production and loss costs.
In this context, the industry also generally believes that full automation and intelligence will be an irreversible new development trend in the equipment industry.
In general, with the continuous improvement of industrial production, the pharmaceutical equipment industry, as the upstream of medicine, is gradually releasing orders and the production capacity is relatively good.
However, in the face of more and more foreign products entering the domestic pharmaceutical industry and competing for the market, the domestic pharmaceutical equipment industry still has considerable shortcomings.
However, in the face of more and more foreign products entering the domestic pharmaceutical industry and competing for the market, the domestic pharmaceutical equipment industry still has considerable shortcomings.
Although some companies have gradually realized overtaking in corners through intelligence, the pharmaceutical equipment market is about to exceed 180 billion yuan and the market competition is becoming more and more fierce.
Pharmaceutical equipment companies still need to continuously improve the automation, informatization, and The level of intelligence and the shift to the role of an overall solution provider can better meet the needs of pharmaceutical companies to reduce costs and increase efficiency and help pharmaceutical companies to further develop.
Pharmaceutical equipment companies still need to continuously improve the automation, informatization, and The level of intelligence and the shift to the role of an overall solution provider can better meet the needs of pharmaceutical companies to reduce costs and increase efficiency and help pharmaceutical companies to further develop.
Original title: Local pharmaceutical machinery companies are beginning to rise, or use intelligence to achieve overtaking in corners
